What conditions have the most trials recruiting in Rotenburg (Wümme), Germany?

In Rotenburg (Wümme), Germany, the conditions with the most recruiting trials are Breast Cancer (2), Breast Neoplasms (2), Chronic kidney disease (2).

Clinical trials recruiting in Rotenburg (Wümme), Germany

Recruiting trials

Conditions

Phase breakdown

Phase 3 4Phase 4 1Not applicable 2

Conditions recruiting in Rotenburg (Wümme), Germany

Condition	Trials
Breast Cancer	2
Breast Neoplasms	2
Chronic kidney disease	2
Hypertension	2
Lung cancer	2
Advanced Breast Cancer	1
Breast Cancer Female	1
Breast Neoplasm Female	1
Carcinoma, Non-Small Cell Lung	1
Cardiovascular Diseases	1
Chronic Kidney Disease and Hypertension	1
Diabetes Mellitus, Type 2	1
HER2-negative Breast Cancer	1
Hormone Receptor-positive Breast Cancer	1
Kidney Disease, Chronic	1

Recruiting trials in Rotenburg (Wümme), Germany

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
NCT06868277 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe
NCT05363319 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
NCT05452213 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Rotenburg (Wümme), Germany?

7 recruiting trials have at least one study site in Rotenburg (Wümme), Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.